Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Generate Biomedicines, Inc.
GENB
Price / sales
Price / sales at other companies
AutoZone
AZO
2.4×
-0.9×
Synopsys
SNPS
10.7×
-0.3×
Northern Trust
NTRS
2.5×
-0.9×
Dycom Industries
DY
2×
+1.0×
Nucor
NUE
1.1×
+0.2×
Berkshire Hathaway
BRK.A
2.8×
-0.3×
Other financials
Income statement
See full
Revenue
$6.3M
-37.7%
Operating income
-$71.6M
-19.1%
Net income
-$67.3M
-28.3%
EPS (diluted)
-$0.52
+73.2%
Balance sheet
See full
Cash & equivalents
$135.4M
-12.3%
Total debt
$62.6M
—
Total equity
$456.0M
+188%
Total assets
$561.7M
—
Cash flow
See full
Operating cash flow
-$57.9M
-18.9%
CapEx
$933.0K
+506%
Free cash flow
-$58.9M
-20.4%
Valuation
See full
Market cap
$1.86B
+19.8%
Enterprise value
$1.78B
—
Profitability
See full
Operating margin
-751.2%
—
Net margin
-685.9%
—
FCF margin
-756.9%
—
Returns & leverage
See full
Return on equity
2,979.4%
—
Debt / equity
0.1×
—
Current ratio
8.3×
—
Watchlist
Screener
Filings
Earnings
Charts